145183-06-8

Upstream product

• 33713-02-9 3-methoxy-4-methyl-5-nitrobenzoic acid methyl ester 
• 33580-39-1 3-Methoxy-5-nitro-p-kresol 
• 859821-10-6 Methyl-(5-nitro-3-hydroxy-4-methyl-phenyl)-aether 
• 16024-31-0 2,4-dimethoxy-6-nitro-toluene 
• 33580-37-9 3-Methoxy-5-nitro-p-toluylsaeureamid 
• 33580-38-0 3-Methoxy-5-nitro-p-toluidin 

Downstream Products

• 23121-32-6 1-(2-hydroxy-4,6-dimethoxy-3-methyl-phenyl)-ethanone 
• 1431873-02-7 C₂₀H₂₀N₆O₂ 
• 33580-41-5 2-Methyl-3,5-dimethoxy-jodbenzol 

Relevant academic research and scientific papers

PYRAZOLYL QUINAZOLINE KINASE INHIBITORS

The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Multisubstituted 1-hydroxy-9-acridones with anticancer activity

The present invention provides a compound having the structure: STR1 The present invention also provides a method for synthesizing a compound having the above-identified structure as well as the intermediate compounds produced according to that method. The present invention further provides a pharmaceutical composition comprising the above compounds. Lastly, the present invention provides a method of inhibiting growth of tumor cells.